Mohamed Sanhoury1, Massimo Moltrasio2, Fabrizio Tundo2, Stefania Riva2, Antonio Dello Russo2, Michela Casella2, Claudio Tondo2, Gaetano Fassini2. 1. Cardiac Arrhythmia Research Centre, Department of Cardiovascular Sciences, University of Milan, Centro Cardiologico Monzino, IRCCS, Via Parea 4, 20138, Milan, Italy. drsanhory@yahoo.com. 2. Cardiac Arrhythmia Research Centre, Department of Cardiovascular Sciences, University of Milan, Centro Cardiologico Monzino, IRCCS, Via Parea 4, 20138, Milan, Italy.
Abstract
PURPOSE: In the present study, we aimed to test the value of CAAP-AF score for prediction of atrial fibrillation (AF) recurrence at follow-up in a group of our patients treated by balloon cryoablation. METHODS: A total of 283 symptomatic drug-refractory AF patients [261 (92%) with paroxysmal AF] who underwent pulmonary vein isolation (PVI) with second-generation cryoballoon between April 2012 and October 2016 were included. The CAAP-AF score was calculated for every patient. RESULTS: A total of 283 patients [68 female (20%), mean age 59.8 ± 11.4 years] were included in the present analysis. Eighty-nine patients (31%) had hypertension and 13 (4%) had coronary artery disease. The mean left atrial diameter and left ventricular ejection fraction were 40.6 ± 7.0 mm and 60.0 ± 9.1%, respectively. The mean CHA2DS2-VASc score was 1.2 ± 1.1, and mean number of prior failed antiarrhythmic drugs was 1.4 ± 0.8. At 18 ± 6 months follow-up, 25 patients (8.87%) developed AF recurrence. The recurrence rate was as follows: 3.17% (score 0-3), 8.47% (score 4), 16.28% (score 5), 6.67% (score 6), 23.08% (score 7), and 36.36% (score ≥8). The recurrence rate was 4.86% at a score <5 and 16.49% at a value ≥5; a score cutoff ≥5 predicted AF recurrence with a sensitivity 64% and specificity 68%. CONCLUSIONS: The present analysis suggests the usefulness of CAAP-AF scoring system, with its simple and easily obtained six clinical variables, to predict AF recurrence after PVI by means of second-generation cryoballoon. A score value ≥5 predicted AF recurrence with a sensitivity 64% and specificity 68%.
PURPOSE: In the present study, we aimed to test the value of CAAP-AF score for prediction of atrial fibrillation (AF) recurrence at follow-up in a group of our patients treated by balloon cryoablation. METHODS: A total of 283 symptomatic drug-refractory AFpatients [261 (92%) with paroxysmal AF] who underwent pulmonary vein isolation (PVI) with second-generation cryoballoon between April 2012 and October 2016 were included. The CAAP-AF score was calculated for every patient. RESULTS: A total of 283 patients [68 female (20%), mean age 59.8 ± 11.4 years] were included in the present analysis. Eighty-nine patients (31%) had hypertension and 13 (4%) had coronary artery disease. The mean left atrial diameter and left ventricular ejection fraction were 40.6 ± 7.0 mm and 60.0 ± 9.1%, respectively. The mean CHA2DS2-VASc score was 1.2 ± 1.1, and mean number of prior failed antiarrhythmic drugs was 1.4 ± 0.8. At 18 ± 6 months follow-up, 25 patients (8.87%) developed AF recurrence. The recurrence rate was as follows: 3.17% (score 0-3), 8.47% (score 4), 16.28% (score 5), 6.67% (score 6), 23.08% (score 7), and 36.36% (score ≥8). The recurrence rate was 4.86% at a score <5 and 16.49% at a value ≥5; a score cutoff ≥5 predicted AF recurrence with a sensitivity 64% and specificity 68%. CONCLUSIONS: The present analysis suggests the usefulness of CAAP-AF scoring system, with its simple and easily obtained six clinical variables, to predict AF recurrence after PVI by means of second-generation cryoballoon. A score value ≥5 predicted AF recurrence with a sensitivity 64% and specificity 68%.
Entities:
Keywords:
Atrial fibrillation; CAAP-AF score; Cryoballoon ablation; Predictors of recurrence
Authors: Roger A Winkle; Julian W E Jarman; R Hardwin Mead; Gregory Engel; Melissa H Kong; William Fleming; Rob A Patrawala Journal: Heart Rhythm Date: 2016-07-17 Impact factor: 6.343
Authors: F D'Ascenzo; A Corleto; G Biondi-Zoccai; M Anselmino; F Ferraris; L di Biase; A Natale; R J Hunter; R J Schilling; S Miyazaki; H Tada; K Aonuma; L Yenn-Jiang; H Tao; C Ma; D Packer; S Hammill; F Gaita Journal: Int J Cardiol Date: 2012-05-22 Impact factor: 4.164
Authors: Humera Ahmed; Petr Neuzil; Jan Skoda; Andre D'Avila; David M Donaldson; Margaret C Laragy; Vivek Y Reddy Journal: J Cardiovasc Electrophysiol Date: 2010-02-01
Authors: Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin Journal: J Am Coll Cardiol Date: 2013-03-21 Impact factor: 24.094
Authors: Karl-Heinz Kuck; Josep Brugada; Alexander Fürnkranz; Andreas Metzner; Feifan Ouyang; K R Julian Chun; Arif Elvan; Thomas Arentz; Kurt Bestehorn; Stuart J Pocock; Jean-Paul Albenque; Claudio Tondo Journal: N Engl J Med Date: 2016-04-04 Impact factor: 91.245
Authors: Sakis Themistoclakis; Robert A Schweikert; Walid I Saliba; Aldo Bonso; Antonio Rossillo; Giovanni Bader; Oussama Wazni; David J Burkhardt; Antonio Raviele; Andrea Natale Journal: Heart Rhythm Date: 2008-01-30 Impact factor: 6.343
Authors: Graham Lohrmann; Albert Liu; Paul Ziegler; João Monteiro; Nathan Varberg; Rod Passman Journal: J Interv Card Electrophysiol Date: 2022-08-02 Impact factor: 1.759
Authors: Michael A Labarbera; Thomas Atta-Fosu; Albert K Feeny; Marjan Firouznia; Meghan Mchale; Catherine Cantlay; Tyler Roach; Alexis Axtell; Paul Schoenhagen; John Barnard; Jonathan D Smith; David R Van Wagoner; Anant Madabhushi; Mina K Chung Journal: IEEE J Transl Eng Health Med Date: 2021-12-09
Authors: Makoto Sano; Christian-Hendrik Heeger; Vanessa Sciacca; Niels Große; Ahmad Keelani; Behzad Hassan Hosseiny Fahimi; Huong Lan Phan; Samuel Reincke; Ben Brüggemann; Thomas Fink; Spyridon Liosis; Julia Vogler; Charlotte Eitel; Roland Richard Tilz Journal: J Interv Card Electrophysiol Date: 2020-07-07 Impact factor: 1.900